drugset / Trial / NCT01764295

Clinical Study for Patients With Hypertension Associated With Dyslipidemia

NCT01764295

Phase 3 Completed 150 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedFactorialTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of DWJ1276

Timeline

Start
2012-09
Primary completion
2013-05
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject DWJ1276 Unknown Oral
Comparator Olmesartan Other / unclassified Oral
Comparator Rosuvastatin Small molecule Oral